Serology Is More Sensitive Than Urea Breath Test or Stool Antigen for the Initial Diagnosis of Helicobacter pylori Gastritis When Compared With Histopathology.


Journal

American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470

Informations de publication

Date de publication:
07 07 2020
Historique:
pubmed: 24 5 2020
medline: 21 10 2020
entrez: 24 5 2020
Statut: ppublish

Résumé

To assess the concordance and performance characteristics of Helicobacter pylori laboratory tests compared with histopathology and to propose algorithms for the diagnosis of H pylori that minimize diagnostic error. H pylori diagnostics were reviewed from a 12-year period within a health system (2,560 cases). Analyses were performed to adjust diagnostic performance based on treatment and consensus histopathologic diagnoses among pathologists. Markers of access to care, including test cancellation frequency and turnaround time, were assessed. Costs and performance of candidate noninvasive testing algorithms were modeled as a function of disease prevalence. Serum H pylori IgG demonstrated a higher sensitivity (0.94) than urea breath and stool antigen tests (0.64 and 0.61, respectively). Evidence of an advantage in access to care for serology included a lower cancellation rate. Interobserver variability was higher (κ = 0.34) among pathologists for cases with a discordant laboratory test than concordant cases (κ = 0.56). A model testing algorithm utilizing serology for first-time diagnoses minimizes diagnostic error. Although H pylori serology has modestly lower specificity than other noninvasive tests, the superior sensitivity and negative predictive value in our population support its use as a noninvasive test to rule out H pylori infection. Reflexive testing with positive serology followed by either stool antigen or urea breath test may optimize diagnostic accuracy in low-prevalence populations.

Identifiants

pubmed: 32445464
pii: 5843308
doi: 10.1093/ajcp/aqaa043
doi:

Substances chimiques

Antigens, Bacterial 0
Urea 8W8T17847W

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-265

Informations de copyright

© American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Dustin E Bosch (DE)

Department of Laboratory Medicine, University of Washington, Seattle.
Department of Pathology, University of Washington, Seattle.

Niklas Krumm (N)

Department of Laboratory Medicine, University of Washington, Seattle.

Mark H Wener (MH)

Department of Laboratory Medicine, University of Washington, Seattle.

Matthew M Yeh (MM)

Department of Pathology, University of Washington, Seattle.

Camtu D Truong (CD)

Department of Pathology, University of Washington, Seattle.

Deepti M Reddi (DM)

Department of Pathology, University of Washington, Seattle.

Yongjun Liu (Y)

Department of Pathology, University of Washington, Seattle.

Paul E Swanson (PE)

Department of Pathology, University of Washington, Seattle.

Rodney A Schmidt (RA)

Department of Pathology, University of Washington, Seattle.

Andrew Bryan (A)

Department of Laboratory Medicine, University of Washington, Seattle.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH